Sana Biotechnology, Inc. (SANA) Tops Q3 EPS by 4c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q3 EPS of ($0.41), $0.04 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg